Mikael Søndergaard Thomsen
Founder chez INITIATOR PHARMA A/S
Profil
Mikael Søndergaard Thomsen is the founder of Bridge Bioresearch Plc (founded in 2010) and Contera Pharma ApS (founded in 2010).
He held the title of Chief Scientific Officer at Bridge Bioresearch Plc from 2010 to 2012 and at Contera Pharma ApS from 2010 to 2014.
He is currently the Director & Chief Scientific Officer at Conrig Pharma ApS, which he founded in 2012.
In 2016, he also founded Initiator Pharma A and holds the position of Chief Development Officer.
Dr. Thomsen is also the founder of Sound Biotechnology, Inc., Oxford UK Ltd, and Prosidion Ltd.
Dr. Thomsen's former jobs include working as a Principal at Novartis Pharma Schweiz AG, the US Food & Drug Administration, Novo Nordisk, Inc., and Vivoryon Therapeutics NV.
In terms of education, Dr. Thomsen graduated and obtained a doctorate degree from the University of Copenhagen.
He also completed his undergraduate studies at the University of Basel.
Postes actifs de Mikael Søndergaard Thomsen
| Sociétés | Poste | Début |
|---|---|---|
| INITIATOR PHARMA A/S | Founder | 01/01/2016 |
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Founder | 20/12/2010 |
Anciens postes connus de Mikael Søndergaard Thomsen
| Sociétés | Poste | Fin |
|---|---|---|
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Founder | 01/01/2014 |
Bridge Bioresearch Plc
 Bridge Bioresearch Plc Medical/Nursing ServicesHealth Services Bridge Bioresearch Plc develops drug for obesity and metabolic disorders. It is a drug development company focusing on general phase 2a clinical trials as well as acquisition of novel drugs for treatment of widespread metabolic disorders, within the field of life style induced diseases such as Obesity, Type 2 Diabetes and Hypertension. The company is headquartered in London, the United Kingdom. | Founder | 31/03/2011 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | - |
| VIVORYON THERAPEUTICS N.V. | Corporate Officer/Principal | - |
| Sound Biotechnology, Inc. | Founder | - |
Formation de Mikael Søndergaard Thomsen
| University of Copenhagen | Doctorate Degree |
| University of Basel | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| INITIATOR PHARMA A/S | Health Technology |
| Entreprise privées | 9 |
|---|---|
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Oxford UK Ltd
 Oxford UK Ltd Financial ConglomeratesFinance Oxford UK Ltd is a private company based in Brighouse, UK. and has subsidiaries in the United Kingdom. The British company was founded by Mikael Søndergaard Thomsen. | Finance |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Bridge Bioresearch Plc
Bridge Bioresearch Plc Medical/Nursing ServicesHealth Services Bridge Bioresearch Plc develops drug for obesity and metabolic disorders. It is a drug development company focusing on general phase 2a clinical trials as well as acquisition of novel drugs for treatment of widespread metabolic disorders, within the field of life style induced diseases such as Obesity, Type 2 Diabetes and Hypertension. The company is headquartered in London, the United Kingdom. | Health Services |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Contera Pharma ApS
Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Sound Biotechnology, Inc. | |
Conrig Pharma ApS
Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
